DSpace Repository

COVID-19 ve NÖROLOJİK HASTALIKLAR

Show simple item record

dc.creator AYDEMİR, Duygu; süleyman demirel üniversitesi
dc.creator TÜRK, Özge; süleyman demirel üniversitesi
dc.creator CEYLAN, Burak; süleyman demirel üniversitesi
dc.creator YILDIRIM, Neslişah; süleyman demirel üniversitesi
dc.creator BAYLAM, Ekin; süleyman demirel üniversitesi
dc.creator KOÇKAR, İsra Nur; süleyman demirel üniversitesi
dc.creator SARIOĞLU, Gizem; süleyman demirel üniversitesi
dc.creator KUTLUHAN, Süleyman; süleyman demirel üniversitesi
dc.creator DEMİRCİ, Serpil; süleyman demirel üniversitesi
dc.creator YÜREKLİ, Yrd. Doç. Dr. Vedat; süleyman demirel üniversitesi
dc.creator KOYUNCUOĞLU, Hasan; süleyman demirel üniversitesi
dc.creator DOĞAN ÜNLÜ, Melike; süleyman demirel üniversitesi
dc.creator ŞENGEZE, Nihat; süleyman demirel üniversitesi
dc.date 2021-06-05T00:00:00Z
dc.date.accessioned 2021-12-03T11:46:58Z
dc.date.available 2021-12-03T11:46:58Z
dc.identifier https://dergipark.org.tr/tr/pub/sdutfd/issue/62643/920618
dc.identifier 10.17343/sdutfd.920618
dc.identifier.uri http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94182
dc.description Covid-19 pandemisinde yapılan araştırmalarda nörolojik belirti ve bulguların hastaların yaklaşık % 36’sında görüldüğü saptanmıştır. Hastalar Covid-19 enfeksiyonunun klasik ateş, öksürük veya solunum sıkıntısı gibi belirtilerinin yanısıra; koku ve/veya tat alma duyusu kaybı, kas ağrısı, inme, baş ağrısı, bilinç bozukluğu, baş dönmesi, epileptik nöbet gibi farklı nörolojik belirtilerle de hastaneye başvurabilmektedir. Bu nörolojik belirti ve bulguların bilinmesi ve bu konudaki farkındalığın artması gerekmektedir. Bu durum, enfeksiyonun yayılmasını önleme ve tedavi etme konusunda oldukça katkı sağlayacaktır.Bu yazı Covid-19 hastalığının şu ana kadar saptanmış olan nörolojik belirtileri ve komplikasyonlarının literatür eşliğinde derlenmesi amacıyla hazırlanmıştır. Bu enfeksiyonla ilgili araştırmalar arttıkça nörolojik tutulumun sanılandan daha fazla olabileceği öngörülmektedir.
dc.description It has been determined that neurological signs and symptoms are seen in approximately 36% of patients in studies conducted during the Covid-19 pandemic.In addition to the classical symptoms of Covid-19 infection such as fever, cough, and respiratory distress; They can also be admitted to the hospital with different neurological symptoms such as loss of sense of smell or taste, muscle pain, stroke, headache, unconsciousness, dizziness, and seizures. It is needed both to know neurological signs and symptoms and to increase awareness of between covid--19 and them. Thus, it will contribute greatly to preventing and treating the spread of the infection.We have been reviewed literature for neurological symptoms and complications of Covid-19.
dc.format application/pdf
dc.language tr
dc.publisher Süleyman Demirel Üniversitesi
dc.publisher Süleyman Demirel University
dc.relation https://dergipark.org.tr/tr/download/article-file/1716993
dc.source Volume: COVID-19 Özel Sayı, Issue: 1 235-240 en-US
dc.source 1300-7416
dc.source 2602-2109
dc.source SDÜ Tıp Fakültesi Dergisi
dc.subject Covid-19,Nörolojik belirtiler,Baş ağrısı,Koku kaybı,tat alma kaybı,epileptik nöbet
dc.subject Covid-19,Neurological symptoms,Headache,sense of Smell,sense of Taste,Seizure
dc.title COVID-19 ve NÖROLOJİK HASTALIKLAR tr-TR
dc.title COVID-19 and NEUROLOGICAL DISORDERS en-US
dc.type info:eu-repo/semantics/article
dc.citation 1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;1;77(6):683-690.
dc.citation 2. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382: e60.
dc.citation 3. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-783.
dc.citation 4. Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020;26(2):143-148.
dc.citation 5. Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020;25 : 1–
dc.citation 6. Bobker SM, Robbins MS. COVID-19 and Headache: A Primer for Trainees. Headache. 2020;60(8):1806-1811.
dc.citation 7. Dufy L, O’Reilly SC. Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments. Immunotargets Ter 2016;5:69–80
dc.citation 8. J.J Houtman, H.C.Hinze, J.O.Fleming, Demiyelination induced by murıne coronavirus JHM infection of congenitally immunodeficient mice, P.J Talbot, G.A.Levy(Eds.), Corona and related Viruses: Current Concepts in Molecular Biology and Pathogenesis, Springer US, Boston, MA 1995;159-163
dc.citation 9. G.F.Wu, S.Perlman. Macrophage infiltration, but not apoptosis is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavırus, J.Vırol., 73(10)(1999), pp.8771-8780
dc.citation 10. Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. [Epub ahead of print], doi:10.1101/2020.03.16.20035105
dc.citation 11. McGonagle D, Sharif K, O'Regan A, Bridgewooda C .The role of cytokines including Interleukin‐6 in COVID‐19 induced pneumonia and macrophage activation syndrome‐like disease. Autoimmun Rev. 2020;9(6):102537.
dc.citation 12. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis .2020; 28;71(15):762-768.
dc.citation 13. Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol.2020:1–19.
dc.citation 14. Koralnik IJ, Tyler KL. COVID-19: A Global Threat to the Nervous System. Ann Neurol 2020;88:1–11.
dc.citation 15. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–8.
dc.citation 16. Huang YH, Jiang D, Huang JT. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun.2020; 87:149.
dc.citation 17. McAbee GN, Brosgol Y, Pavlakis S, Agha R, Gaffoor M. Encephalitis associated with COVID-19 infection in an 11-year-old child. Pediatr Neurol. 2020;109:94.
dc.citation 18. Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun. 2020;87:33.
dc.citation 19. Leonhard SE, Mandarakas MR, Gondim FAA, Doorn van PA, Bateman K, Ferreira MLB, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–83.
dc.citation 20. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;13; 388(10045):717–27.
dc.citation 21. Kieseier BC, Mathey EK, Sommer C, Hartung HP. Immune-mediated neuropathies. Nat Rev Dis Primers. 2018;11;4(1):31.
dc.citation 22. Wakerley BR, Yuki N. Polyneuritis cranialis-subtype of Guillain-Barré syndrome? Nat Rev Neurol 2015; 11(11):664.
dc.citation 23. Uncini A, Kuwabara S. The electrodiagnosis of Guillain Barré syndrome subtypes: Where do we stand? Clin Neurophysiol. 2018;129(12):2586-93.
dc.citation 24. Kim JE, Heo JH, Park SS, Park TH, Ahn JY, Kim MK, et al. Neurological complications during treatment of middle east respiratory syndrome. J. Clin. Neurol. 2017;13(3):227–33.
dc.citation 25. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-84.
dc.citation 26. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barre Syndrome associated with SARS CoV-2. N Engl J Med 2020;25;382(26):2574-6
dc.citation 27. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J. Clin. Neurosci. 2020;76:233-5.
dc.citation 28. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5): 383–4.
dc.citation 29. Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG, et al. Guillain-Barre syndrome following COVID-19: new infection, old complication? J. Neurol. 2020;267(7):1877-9.
dc.citation 30. Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barre syndrome related to COVID-19 infection. Neurol. Neuroimmunol. Neuroinflamm. 2020;7 (4):e741.
dc.citation 31. Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P. Guillain-Barre syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report. SAGE Open Med Case Rep. 2019;21;7:2050313x19838750.
dc.citation 32. Netravathi M, Pal PK, Devi BI. A clinical profile of 103 patients with secondary movement disorders: Correlation of etiology with phenomenology. Eur. J. Neurol. 2012;19(2):226-33.
dc.citation 33. Alarcon F, Zijlmans JCM, Duenas G, Cevallos N. Post-stroke movement disorders: Report of 56 patients. J. Neurol. Neurosurg. Psychiatry. 2004;75(11):1568-74.
dc.citation 34. Rabano-Suarez P, Bermejo-Guerrero L, Mendez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sanchez-Tejerina D, et al. Generalized myoclonus in COVID-19. Neurology. 2020;95(6):767-72.
dc.citation 35. Mendez-Guerrero A, Laespada-García MI, Gomez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, et al. Acute hypokinetic-rigid syndrome following SARS CoV-2 infection. Neurology. 2020;13;95(15):2109-18.
dc.citation 36. Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, et al. A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19(10):804-5.
dc.citation 37. Costello F, Dalakas MC. Cranial neuropathies and COVID-19 neurotropism and autoimmunity. Neurology. 2020:195-6
dc.citation 38. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirüs pneumonia in Wuhan, China: a descriptive study. Lancet 2020;15: 507-13.
dc.citation 39. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014;29: 301-6
dc.citation 40. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020;21: 7352.
dc.citation 41. Asadi-Pooya AA, Attar A, Moghadami M, Karimzadeh I. Management of COVID-19 in people with epilepsy: drug considerations. Neurol Sci 2020;8:2005–11
dc.citation 42. Huang S, Wu C, Jia Y, Li G, Zhu Z, Lu K, et al. COVID‐19 outbreak: The impact of stress on seizures in patients with epilepsy. Epilepsia.2020;9: 1884-93.
dc.citation 43. Kichloo A, Albosta M, Dettloff K, Wani F, El-Amir Z, Singh J, et al Telemedicine, the current COVID-19 pandemic and the future a narrative review and perspectives moving forward in the USA Family Medicine and Community Health.2020;3:530
dc.citation 44. Gogia B, Guevare AG, Rai PK, Fang X.A case of Covid-19 with multiple cranial neuropathies. International journal of neuroscience. 2020;30; 1-3
dc.citation 45. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19 Neurology, 2020;25: 1060-70.
dc.citation 46. P. Agarwal, S.Ray, A. Madan, B. Tyson Neurological manifestations in 404 COVID-19 patients in Washington State J Neurol.2021;3: 770-72
dc.citation 47. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L,et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patient a cross-sectional study Clin Infect Dis. 2020;28: 889-90
dc.citation 48. Romero-Sánchez CM, Díaz-MarotoI I, Fernández-Díaz E., Sanchez-Larsen A.,Layos-Romero A. Garcia-Garcia J, et al. Neurologic manifestations in hospitalized patients with COVID-19. Neurology. 2020;25:1060-70
dc.citation 49. Selvaraj V. Sacchetti D, Finn A, Dapaah-Afriyie K. Acute Vision Loss in a Patient with COVID-19.R I Med 2020;10: 37–38.


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account